Vulvar Aphthous Ulcer Following Pfizer-BioNTech COVID-19 Vaccine – A Case Report - 18/03/22
, Kellianne Corrao, MD, Mallory Gandy, MD
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Background |
In this case report, we describe a potential association between the Pfizer-BioNTech COVID-19 vaccine and development of a vulvar aphthous ulcer in a virginal 14-year-old girl.
Case |
A 14-year-old patient reported vulvar pain and visible lesion. Exam findings were consistent with vulvar aphthous ulcers. Two days prior to the onset of her symptoms she received her second Pfizer-BioNTech COVID-19 vaccine. The evening of vaccine administration, she experienced several hours duration of fatigue, muscle aching and insomnia but had otherwise been recently healthy and testing for common viral associations of vulvar ulcers was negative.
Summary and Conclusion |
Vaccination, in general, has been associated with mucosal side-effects and oral ulceration has been reported in subjects who received Pfizer-BioNTech COVID-19 vaccine. It is reasonable to hypothesize that vulvar ulceration may be caused by a similar mechanism and should be considered a rare side effect of this vaccine.
Le texte complet de cet article est disponible en PDF.Keywords : Vulvar ulcer, Pfizer vaccine, COVID-19 vaccine, Aphthous ulcer, COVID-19
Plan
| Declaration of Competing Interest: The above listed authors, Abigail Drucker, Kellianne Corrao, and Mallory Gandy, certify that we have no conflicts of interest. |
Vol 35 - N° 2
P. 165-166 - avril 2022 Retour au numéro
Article précédent
- Nitrous Oxide Use for Intrauterine System Placement in Adolescents
- Kylie G. Fowler, Gita Byraiah, Cassaundra Burt, Daniel B. Lee, Rachel J. Miller
- Vulvar Aphthous Ulcer in an Adolescent After Pfizer-BioNTech (BNT162b2) COVID-19 Vaccination
- Anna V. Wojcicki, Katherine L. O'Flynn O'Brien
Bienvenue sur EM-consulte, la référence des professionnels de santé.